HomeBIAF • NASDAQ
add
bioAffinity Technologies Inc
Previous close
$2.12
Day range
$1.58 - $1.95
Year range
$0.69 - $46.53
Market cap
8.59M USD
Avg Volume
8.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.59M | -27.85% |
Operating expense | 3.83M | 6.62% |
Net income | -3.14M | -5.75% |
Net profit margin | -196.98 | -46.56% |
Earnings per share | — | — |
EBITDA | -3.02M | -8.26% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.45M | 483.54% |
Total assets | 10.96M | 68.27% |
Total liabilities | 3.68M | -5.84% |
Total equity | 7.28M | — |
Shares outstanding | 4.49M | — |
Price to book | 1.31 | — |
Return on assets | -69.69% | — |
Return on capital | -87.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.14M | -5.75% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Headquarters
Website
Employees
57
